跳至主要内容
临床试验/CTRI/2025/05/086430
CTRI/2025/05/086430尚未招募不适用

To compare the effectiveness of a Mobile-Application based educational intervention Vs. Routine care along with booklet based education on Anticoagulation treatment compliance, knowledge and INR control among Cerebral Venous Thrombosis (CVT) Stroke patients on anticoagulation therapy at a tertiary care centre A Randomized Control Trial

NIMHANS1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年5月31日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
NIMHANS
入组人数
60
试验地点
1
主要终点
1. Anticoagulation knowledge

研究概览

简要总结

cerebral Venous Thrombosis (CVT) is a rare but potentially life-threatening condition characterized by the formation of blood clots in the cerebral veins. Effective management of CVT includes anticoagulation therapy, strict medication adherence, and close monitoring of the International Normalized Ratio (INR) to prevent the complications of CVT stroke patients. Bleeding, recurrence of thrombosis, INR fluctuations, drug interactions are complications or adverse outcomes in the management of CVT patients. This randomized controlled trial (RCT) to assess and compare the utility of two distinct educational interventions, a Mobile –Application based educational intervention and Routine care along with booklet –based education on Anti Coagulation Compliance, knowledge and INR control among Cerebral Venous Thrombosis (CVT) Stroke patients.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients aged above 18 years old to 75 years old.
  • 2.Patient who developed cerebral venous thrombosis stroke.
  • 3.Patients who have Smartphones.
  • 4.Patient willing to participate in the study 5.Patients who can understand Kannada or English language.

排除标准

  • 1.Patients who have any chronic and mental disease.
  • 2.Patients who have any other major surgery.
  • 3.Patients who have bleeding disorders.
  • 4.Previously had a structured education about warfarin.
  • 5.Patients who have visual or hearing impairment.

结局指标

主要结局

1. Anticoagulation knowledge

时间窗: Base line, one month, three months and six months

2. Anticoagulation compliance

时间窗: Base line, one month, three months and six months

次要结局

  • 1. INR CONTROL(Base line, one month, three months & six months)

研究者

发起方
NIMHANS
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

DR GOPICHANDRAN L

NATIONAL INSTITUTE OF MENTAL HEALTH AND NEURO SCIENCES,BANGALORE

研究点 (1)

Loading locations...

相似试验